BIN1 and Alzheimer disease: Validation of the gene targets for functional regulatory variants can be tested using CRISPR excision of gene regulatory regions, as demonstrated for two BIN1 enhancers harbouring AD risk variants rs6733839 (98) and rs1302717 (106) (Figure 2).